Copy to clipboard 
After nearly four years, first serving as Chairman of the Board and soon after becoming CEO of Elos Medtech, Stefano Alfonsi will step down from his position as CEO for personal reasons by November 1, 2025. He will remain a member of the Board of Directors.
Mr. Alfonsi has shaped Elos’ strategy, strengthened the commercial and customer focus, significantly expanded global capabilities with the Klingel acquisition and has taken Elos private.
Company representation stated, “We appreciate Stefano’s ambitious leadership and his steadfast commitment to reimagining partnerships to enhance lives.
“Looking forward, we are pleased to share that Winfried Schaller, who has served on our Board of Directors for the past two and a half years, will assume the role of CEO. Having collaborated closely with our senior leadership, Winfried possesses keen insight into our business, is strongly aligned with our values and shares our dedication to a customer first approach and our growth and innovation journey ahead.”
Mr. Schaller is a seasoned leader with more than 30 years of international leadership experience, including a term as CEO of the Lincotek Group from 2018 through 2022. His deep expertise in strategy, operational transformation, and M&A is expected to be instrumental in leading Elos into its next phase of growth and innovation.
The company affirmed, “To all employees, customers, and partners — thank you for your ongoing trust. We remain committed to delivering exceptional value through innovation, partnership, and aiming for excellence in everything we do.”
Source: Elos Medtech
